Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Dianatpour

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Iranian Journal of Basic Medical Sciences|March 1, 2021
Use of dual-transfection for programmed death cell protein 1 disruption mediated by CRISPR-Cas9 in human peripheral blood mononuclear cellsSeyedAli Alambeladi, SeyedEbrahim Hosseiny, Mojtaba Jafarinia, et al.
Clinical Laboratory|February 7, 2017
The Evaluation of Cancer Testis Gene PIWIL2 Expression Levels as a New Prognostic Biomarker for Breast CancerFatima M Sarvestani, Akbar Safaei, Abdolrasoul Talei, et al.
Iranian Journal of Medical Sciences|May 25, 2016
Report of a Case with Trisomy 9 MosaicismMohammad Miryounesi, Mehdi Dianatpour, Zahra Shadmani, et al.
Metabolic Syndrome and Related Disorders|November 1, 2022
Analysis of DYRK1B, PPARG, and CEBPB Expression Patterns in Adipose-Derived Stem Cells from Patients Carrying DYRK1B R102C and Healthy Individuals During AdipogenesisAzam Armanmehr, Hossein Jafari Khamirani, Sina Zoghi, et al.
EXCLI Journal|March 21, 2020
CRISPR/Cas9-mediated knockout of MLL5 enhances apoptotic effect of cisplatin in HeLa cells <i>in vitro</i>Mohammad Pirouzfar, Farshid Amiri, Mehdi Dianatpour, et al.
Clinical Laboratory|May 25, 2016
Expression Levels of MMP9 and PIWIL2 in Prostate Cancer: a Case-Control StudyNegar Pouyanfar, Ahmad Monabbati, Alireza Amin Sharifi, et al.
Gene|March 10, 2023
NRXN3 mutations cause developmental delay, movement disorder, and behavioral problems: CRISPR edited cells based WES resultsNeda Kamal, Hossein Jafari Khamirani, Mahintaj Dara, et al.
Avicenna Journal of Medical Biotechnology|May 20, 2021
Using CRISPR/Cas9 System to Knock out Exon 48 in <i>DMD</i> GeneMahintaj Dara, Vahid Razban, Mahdieh Talebzadeh, et al.
Biochemical and Biophysical Research Communications|November 20, 2024
Integrating CRISPR technology with exosomes: Revolutionizing gene delivery systemsMahintaj Dara, Mehdi Dianatpour, Negar Azarpira, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 26, 2019
Targeting the BRAF Signaling Pathway in CD133pos Cancer Stem Cells of Anaplastic Thyroid CarcinomaFarzaneh Bozorg-Ghalati, Mehdi Hedayati, Mehdi Dianatpour, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Iranian Journal of Basic Medical Sciences|March 1, 2021
Use of dual-transfection for programmed death cell protein 1 disruption mediated by CRISPR-Cas9 in human peripheral blood mononuclear cellsSeyedAli Alambeladi, SeyedEbrahim Hosseiny, Mojtaba Jafarinia, et al.
Clinical Laboratory|February 7, 2017
The Evaluation of Cancer Testis Gene PIWIL2 Expression Levels as a New Prognostic Biomarker for Breast CancerFatima M Sarvestani, Akbar Safaei, Abdolrasoul Talei, et al.
Iranian Journal of Medical Sciences|May 25, 2016
Report of a Case with Trisomy 9 MosaicismMohammad Miryounesi, Mehdi Dianatpour, Zahra Shadmani, et al.
Metabolic Syndrome and Related Disorders|November 1, 2022
Analysis of DYRK1B, PPARG, and CEBPB Expression Patterns in Adipose-Derived Stem Cells from Patients Carrying DYRK1B R102C and Healthy Individuals During AdipogenesisAzam Armanmehr, Hossein Jafari Khamirani, Sina Zoghi, et al.
EXCLI Journal|March 21, 2020
CRISPR/Cas9-mediated knockout of MLL5 enhances apoptotic effect of cisplatin in HeLa cells <i>in vitro</i>Mohammad Pirouzfar, Farshid Amiri, Mehdi Dianatpour, et al.
Clinical Laboratory|May 25, 2016
Expression Levels of MMP9 and PIWIL2 in Prostate Cancer: a Case-Control StudyNegar Pouyanfar, Ahmad Monabbati, Alireza Amin Sharifi, et al.
Gene|March 10, 2023
NRXN3 mutations cause developmental delay, movement disorder, and behavioral problems: CRISPR edited cells based WES resultsNeda Kamal, Hossein Jafari Khamirani, Mahintaj Dara, et al.
Avicenna Journal of Medical Biotechnology|May 20, 2021
Using CRISPR/Cas9 System to Knock out Exon 48 in <i>DMD</i> GeneMahintaj Dara, Vahid Razban, Mahdieh Talebzadeh, et al.
Biochemical and Biophysical Research Communications|November 20, 2024
Integrating CRISPR technology with exosomes: Revolutionizing gene delivery systemsMahintaj Dara, Mehdi Dianatpour, Negar Azarpira, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 26, 2019
Targeting the BRAF Signaling Pathway in CD133pos Cancer Stem Cells of Anaplastic Thyroid CarcinomaFarzaneh Bozorg-Ghalati, Mehdi Hedayati, Mehdi Dianatpour, et al.
Pageof 10